The logic of prevention of glaucomatous damage progression

Current Opinion in Ophthalmology

Volumn 8, Issue 2, 1997, Pages 64-67

  Haefliger, Ivan O ^a   Flammer, Josef ^a  

^a UNIVERSITY EYE CLINIC   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; NEUROPATHY; OPTIC NERVE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SHORT SURVEY;

EID: 0030737499     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199704000-00012     Document Type: Short Survey

References (33)

1. Shields MB: Primary open-angle glaucoma. In Textbook of Glaucoma, edn 3, Edited by Shields MB. Baltimore MD: Williams and Wilkins; 1992:431-629.
2. Weber J, Koll W, Krieglstein GK: Intraocular pressure and visual-field decay in chronic glaucoma. Ger J Ophthalmol 1993, 2:165-169.
3. Flammer J, Gasser P, Prünte Ch, Yao K: The probable involvement of factors other than ocular pressure in the pathogenesis of glaucoma. In Pharmacology of Glaucoma. Edited by Drance SM, Buskirk Van EM, Neufeld AH. Baltimore MD: Williams and Wilkins; 1992:273-283.
4. Spaeth GL: Proper outcome measurements regarding glaucoma: the inadequacy of using intraocular pressure alone. Eur J Ophthalmol 1996, 6:101-105.
5. Flammer J: Psychophysics in glaucoma: a modified concept of the disease. In Proceedings of the European Glaucoma Society, Second European Glaucoma Symposium, Helsinki 1984. Edited by Greve EL, Leydhecker W und Raitta C. Dordrecht: Junk; 1985.
6. Flammer J: To what extent are vascular factors involved in the pathogenesis of glaucoma? In Ocular Blood Flow. Edited by Kaiser HJ, Flammer J, Hendrickson Ph. Basel, Switzerland: Karger; 1996:12-39. An extensive and up to date summary of the various evidences leading to the concept of vascular risk factor associated with glaucoma.
7. Orgül S, Flammer J, Gasser P: Female preponderance in normal-tension glaucoma. Ann Ophthalmol Glaucoma 1995, 27:355-359.
8. Flammer J, Guthauser U, Mahler M: Do ocular vasospasms help cause low-tension glaucoma? Doc Ophthalmol Proc Series 1987, 49:397-399.
9. Flammer J: The vascular concept of glaucoma. Surv Ophthalmol 1994, 38:3-6.
10. Haefliger IO, Flammer J: Le syndrome vasospastique un facteur de risque associé au glaucome. In Glaucomes, edn 2. Edited by Béchetoille A. Nantes, France: Jappernard; 1997 (in press).
11. Guthauser U, Flammer J, Mahler F: The relationship between digital and ocular vasospasm. Graefe's Arch Clin Exp Ophthalmol 1988, 226:224-226.
12. Kaiser HJ, Flammer J: Systemic hypotension: a risk factor for glaucomatous damage. Ophthalmologica 1991, 203:105-108.
13. Kaiser HJ, Flammer J, Graf Th, Stümpfig D: Systemic blood pressure in glaucoma patients. Graefe's Arch Clin Exp Ophthalmol 1993, 231:677-680.
14. Hayreh SS, Zimmerman BM, Podhajsky P, Alward WLM: Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994, 117:603-624.
15. Demailly P, Cambien F, Plouin F, Baron P, Chevallier B: Do patients with low-tension glaucoma have particular cardiovascular characteristics? Ophthalmologica 1984, 188:65-75.
16. Béchetoille A, Bresson-Dumont H: Diurnal and nocturnal blood pressure drops in patients with local ischemic glaucoma. Graefe's Arch Clin Exp Ophthalmol 1994, 232:675-679.
17. Graham SL, Drance SM, Wijsman K, Douglas GR, Mikelberg S: Ambulatory blood-pressure monitoring in glaucoma. Ophthalmology 1995, 102:61-69.
18. Gasser P, Flammer J: Blood-cell velocity in the nailfold capillaries of patients with normal-tension or high-tension glaucoma and of healthy controls. Am J Ophthalmol 1991, 111:585-588.
19. Stroman GA, Stewart WC, Golnik KC, Curé JK, Olinger R: Magnetic resonance imaging in patients with low-tension glaucoma. Arch Ophthalmol 1995, 113:168-172.
20. Kaiser HJ, Flammer J, Burckhardt D: Silent myocardial ischemia in glaucoma patients. Ophthalmology 1993, 207:6-8.
21. Pillunat LE, Lang GK, Harris A: The visual response to increased ocular blood flow in normal pressure glaucoma. Surv Ophthalmol 1994, 38(suppl):S139-S148.
22. Gasser P, Flammer J: Short- and long-term effect of nifedipine on the visual field of patients with presumed vasospasm. J Intern Med Res 1990, 18:334-339.
23. Kitazawa J, Shirai H, Go FJ: The effect of calcium antagonist on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 1989, 227:408-412.
24. Flammer J: Therapeutical aspects of normal-tension glaucoma. Curr Opin Ophthalmol 1993, 4:58-64.
25. Meyer P, Lang MG, Flammer J, Lüscher TF: Effect of calcium-channel blockers on the response to endothelin-1, bradykinin and sodium nitroprusside in porcine ciliary arteries. Exp Eye Res 1995, 60:505-510.
26. Flammer J, Guthauser U: Behandlung chorioidaler Vasospasmen mit Kalziumantagonisten. Klin Mbl Augenheilk 1987, 190:299-300.
27. Netland PA, Chaturvedi N, Dreyer EB: Calcium channel blockers in the management of low-tension glaucoma and open-angle glaucoma. Am J Ophthalmol 1993:115:608-613.
28. Gaspar AZ, Flammer J, Hendrickson Ph: Influence of nifedipine on the visual fields of patients with optic nerve head diseases. Eur J Ophthalmol 1994, 1:24-28.
29. Kanellopoulos AJ, Erickson KA, Netland PA: Systemic calcium channel blockers and Glaucoma. J of Glaucoma 1996;5:357-362. A review on the use of calcium channel blockers as an additional treatment for glaucoma.
30. Lumme P, Tuulonen A, Airaksinen PJ, Alanko HI: Neuroretinal rim area in low-tension glaucoma: effect of nifedipine and acetazolamide compared to no treatment. Acta Ophthalmol 1991, 69:293-298.
31. Liu S, Araujo SV, Spaeth GL, Katz LJ, Smith MS: Lack of effect of calcium channel blockers on open-angle glaucoma. J Glaucoma 1996, 5:187-190.
32. Dettmann ES, Lüscher TF, Flammer J, Haefliger IO: Modulation of endothelin-1-induced contractions by magnesium/calcium in porcine ciliary arteries. Graefe's Arch Clin Exp Ophthalmol 1997, in press.
33. Gaspar AZ, Gasser P, Flammer J: The influence of magnesium on visual field and peripheral vasospasm in glaucoma. Ophthalmologica 1995, 209:11-13.